Literature DB >> 3089578

Primary malignant lymphoma of the central nervous system.

C R Freeman, C Shustik, M L Brisson, K Meagher-Villemure, I Dylewski.   

Abstract

Between 1960 and 1983, 19 patients with primary malignant lymphoma of the central nervous system (CNS) were seen at McGill University Hospitals. The diagnosis was made at autopsy in 3 patients, and by biopsy in 16. Results of treatment were poor. All four patient who underwent surgery alone died within 2 months of diagnosis. Of 12 patients who underwent surgery and postoperative radiotherapy, 11 died between 2 and 56 months (median, 12 months) following diagnosis, and one is alive with disease at 47 months. Patterns of involvement at first recurrence and/or at autopsy were analyzed for 13 patients. Failure at the original site of involvement was unusual after treatment consisting of surgery and radiotherapy. In contrast, failure in the brain at sites other than those originally involved was common in spite of the use of whole brain irradiation. Local leptomeningeal involvement was seen in one patient whose diagnosis was made at autopsy, and cerebral spinal fluid seeding was seen in two additional patients, one within 1 month of diagnosis and one at relapse at 6 months after diagnosis. No patient developed disease outside the CNS. The limitations of current therapy for this disease are discussed, and certain suggestions made regarding the management of future patients with this diagnosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089578     DOI: 10.1002/1097-0142(19860901)58:5<1106::aid-cncr2820580521>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

Review 1.  Primary cerebral malignant non-Hodgkin's lymphomas: a retrospective clinical study.

Authors:  D F Braus; K Schwechheimer; H K Müller-Hermelink; G Schwarzkopf; B Volk; F Mundinger
Journal:  J Neurol       Date:  1992-03       Impact factor: 4.849

2.  Diagnosis of primary cerebral lymphoma with particular reference to CT-guided stereotactic biopsy.

Authors:  W Feiden; K Bise; U Steude
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

3.  Primary Renal Lymphoma - A Case Report and Review of Literature.

Authors:  Shraddha Shetty; Avinash Chandra Singh; Vinod Babu
Journal:  J Clin Diagn Res       Date:  2016-09-01

4.  A new xenograft model of primary central nervous system lymphoma.

Authors:  M Saini; M Bellinzona; W Weichhold; M Samii
Journal:  J Neurooncol       Date:  1999-06       Impact factor: 4.130

5.  Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: response to therapy and quality of life of patients.

Authors:  N Guha-Thakurta; D Damek; C Pollack; F H Hochberg
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

6.  Primary central nervous system lymphoma: variety of clinical manifestations and survival.

Authors:  D G Kim; D H Nam; H W Jung; K S Choi; D H Han
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

7.  Primary central nervous system lymphoma in Japan--a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan.

Authors:  T Hayakawa; K Takakura; H Abe; T Yoshimoto; R Tanaka; K Sugita; H Kikuchi; T Uozumi; T Hori; H Fukui
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Prognosis of primary central nervous system lymphoma treated with radiotherapy alone.

Authors:  Senzo Taguchi; Yasushi Hamamoto; Takashi Fujii; Takashi Ochi; Hironobu Harada; Takanori Ohnishi; Teruhito Mochizuki
Journal:  Jpn J Radiol       Date:  2012-09-11       Impact factor: 2.374

Review 9.  Primary central nervous system lymphomas--an update.

Authors:  K A Jellinger; W Paulus
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

10.  Onset of primary brain T-lymphoma simulating a progressive leukoencephalopathy.

Authors:  L Provinciali; M Signorino; G Ceravolo; U Pasquini
Journal:  Ital J Neurol Sci       Date:  1988-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.